• Home
  • About
  • Blog
  • Insights
  • FAQ
Menu

Out-Thinking Parkinson's

Progressive Symptom Reduction Strategies for Parkinson's Disease
  • Home
  • About
  • Blog
  • Insights
  • FAQ

Dopamine Breakdown and Parkinson's Disease: Part 1

April 10, 2024

Introduction

There is little doubt that dopamine plays a key role in the symptoms of those of us with a Parkinson’s Disease diagnosis. However, there are now lots of reasons to believe that the old, nocebo effect [negative belief of hopelessness], narrative of “dopamine producing cells dying in the substantia nigra part of the brain” is not the real story.

For example, we have previously explored the biosynthesis of dopamine via the phenylalamine->tyrosine->l-dopa pathway, and seen how this biochemistry can go awry due to reversible chronic stress, nutritional effects, and pathogens, causing apparent dopamine deficits, without needing to resort to the “cell death” narrative.

We have also explored the role of dopamine cell receptors, and seen how the reversible internationalization or sequestration of the cell receptors inside the cell, causes them to then be no longer available for docking with dopamine molecules, making the cells less sensitive to dopamine, rather than cell death per se.

In this follow up article, we will explore the various ways by which dopamine is chemically broken down, degraded, or metabolized. In doing so, we will provide yet another, more hopeful, story, that the reversible problem may be more to do with the breakdown of dopamine occurring too fast after it has been synthesized, rather than cells dying.

Enzymes

Enzymes are biological catalysts which greatly speed up specific biochemical reactions, e.g. in the human brain and body. Relevant to Parkinson’s Disease is the role of enzymes in the breakdown rates of dopamine. In rare genetic disorders, the body creates not enough or too much of specific enzymes, which can, in turn, result in severe problems due to too little or too much dopamine. However, in folks with PD and other chronic stress conditions, certain enzymes may be insufficiently active or overactive, and hence mimic rare genetic disorders.

The MAo pathway

One way by which dopamine is broken down is via the monoamine oxidase (MAO) enzyme. There are two forms of MAO: MAO-A and MAO-B, with MAO-B being the most relevant one for dopamine. The MAO pathway first breaks down dopamine to a chemical called DOPAL, an aldehyde, plus hydrogen peroxide and ammonia.

DOPAL is in turn is degraded to form another chemical, DOPAC. The breakdown of DOPAL requires the action of another enzyme, called aldehyde dehydrogenase (ALDH). If there is insufficient ALDH, or the MAO-B breaks down dopamine faster than ALDH can keep up, then DOPAL can build up to toxic [to the neurons] levels.

One reason ALDH might not be available is that it may be having to constantly deal with other exposures to other aldehydes. Other sources of aldehydes include: alcohol, certain foods, especially fried foods, perfumes and cosmetics, fungal infections [candida], new carpets and off-gassing from furniture. Exposure to these sources of aldhehdyes should be minimized for folks who are supplementing with endogenous dopamine.

DOPAC is then broken down by another enzyme, COMT, to Homovanillic Acid (HVA), which can then be excreted in the urine. Some studies suggest that HVA levels in the blood may be a proxy for dopamine levels in the brain.

In PD, the MAO pathway may be overactive or there may be too much of the enzyme present, so that dopamine is quickly broken down. MAO seems to increase with age in humans. Importantly for folks with PD, there is also some evidence chronic stress is associated with increased MAO activity, and hence with faster breakdown of dopamine.

Mao Inhibitors

Various pharmaceutical and natural substances can inhibit the action of MAO, with the effect that dopamine stays around longer without being broken down by the MAO parhway. For example, MAO-B inhibitors can be used alongside l-dopa supplementation, with less wear off and longer “on” times for each dose, albeit with the potential for more side-effects.

Rasagiline (Azilect) and Selegiline are examples of pharmaceutical MAO-B inhibitors, while wild green oat extract and the chinese herb Ho Shou Wu/Fo Ti/Polygonum Multiflorum, are examples of naturally occuring MAO-B inhibitors. Apparently, the Ho Shou herb is already used widely in China by people with PD.

Passionflower extract also apparently has some non-selective MAO inhibitor activity. There a few limited studies of its beneficial use for PD but studies not specific to PD also indicate a number of favourable benefits including increased dopamine levels in the brain, as well as sleep and mood improvement.

Licorice root [not the candy] has shown benefits for folks with PD, in part because it also has non-selective MAO inhibitor activity.

Care is needed while taking non-selective MAO inhibitors, which block MAO-A as well MAO-B, together with other medications, and eating cheese [due to the tyramine], which carries the risk of hypertensive crisis, but MAO-B specific inhibitors don’t have this problem.

However, the best, and most natural, way to inhibit excessive MAO-B activity is to reduce chronic stress.

In Brain Science, Diet & Supplements, Therapies Tags Neurotransmitters, Dopamine, Biology
← Stuck on Pause with Parkinson's DiseaseFright and Parkinson's Disease →

ABOUT

Out-Thinking Parkinson's
Out-Thinking Parkinson's Research

 Join my Facebook Group

Follow me on substack:

BLOG

  • Re-thinking Movement
  • Digest
  • People
  • Mental Health
  • Diet & Supplements
  • Therapies
  • Toys
  • Exercise
  • Video
  • Assistive Technology
  • Music
  • Biography
  • Brain Science
  • Books
Parkinson's Disease Carousel: Original Articles and Ideas
Feb 19, 2025
The Nervous System and Parkinson's Disease
Feb 19, 2025
Feb 19, 2025
Sep 19, 2024
Hope and Parkinson's Disease
Sep 19, 2024
Sep 19, 2024
Aug 3, 2024
DAT Scans and Parkinson's Disease
Aug 3, 2024
Aug 3, 2024
Jun 23, 2024
Dopamine Breakdown and Parkinson's Disease: Part 2
Jun 23, 2024
Jun 23, 2024
May 3, 2024
Stuck on Pause with Parkinson's Disease
May 3, 2024
May 3, 2024
Apr 10, 2024
Dopamine Breakdown and Parkinson's Disease: Part 1
Apr 10, 2024
Apr 10, 2024
Jan 2, 2024
Fright and Parkinson's Disease
Jan 2, 2024
Jan 2, 2024
Sep 16, 2023
Acetylcholine, Dopamine and Parkinson's Disease
Sep 16, 2023
Sep 16, 2023
Jul 24, 2023
Sleep and Parkinson's Disease, Part 2
Jul 24, 2023
Jul 24, 2023
Jun 4, 2023
Emotional Armouring and Parkinson's Disease
Jun 4, 2023
Jun 4, 2023
Apr 2, 2023
Histamine, Allergies and Parkinson's Disease
Apr 2, 2023
Apr 2, 2023
Feb 8, 2023
Fascia Decompression and Parkinson's Disease
Feb 8, 2023
Feb 8, 2023
Dec 30, 2022
Lack of Oxygen to the Brain in Parkinson's Disease
Dec 30, 2022
Dec 30, 2022
Dec 13, 2022
Constipation and Parkinson's Disease
Dec 13, 2022
Dec 13, 2022
Oct 19, 2022
The Endocannabinoid System and Parkinson's Disease
Oct 19, 2022
Oct 19, 2022
Aug 21, 2022
Tremors and Parkinson's Disease
Aug 21, 2022
Aug 21, 2022
Jun 29, 2022
The Neck and Parkinson's Disease, Part 2
Jun 29, 2022
Jun 29, 2022
May 17, 2022
Reducing Stress and Parkinson's Disease
May 17, 2022
May 17, 2022
Apr 7, 2022
Thiamine and Parkinson's Disease
Apr 7, 2022
Apr 7, 2022
Mar 6, 2022
Stress, Situations, Symptoms and Parkinson's Disease
Mar 6, 2022
Mar 6, 2022
Feb 18, 2022
Early Retirement and Parkinson's Disease
Feb 18, 2022
Feb 18, 2022
Feb 3, 2022
Survival Instincts and Parkinson's Disease
Feb 3, 2022
Feb 3, 2022
Dec 13, 2021
Feeling Trapped and Parkinson's Disease
Dec 13, 2021
Dec 13, 2021
Nov 4, 2021
Motivation, Pleasure, Pain and Parkinson's Disease
Nov 4, 2021
Nov 4, 2021
Oct 2, 2021
Dopamine Cell Receptors and Parkinson's Disease
Oct 2, 2021
Oct 2, 2021
Aug 15, 2021
Dopamine and Parkinson's Disease
Aug 15, 2021
Aug 15, 2021
Jul 26, 2021
Visual Cues and Parkinson's Disease
Jul 26, 2021
Jul 26, 2021
Jul 10, 2021
The Eyes and Parkinson's Disease
Jul 10, 2021
Jul 10, 2021
Jun 25, 2021
Eye Exercises and Parkinson's Disease
Jun 25, 2021
Jun 25, 2021
Jun 9, 2021
Podcast Therapy and Parkinson's Disease
Jun 9, 2021
Jun 9, 2021

insights

  • Person with PD
  • Caregiver
  • Reader
  • Author
  • Therapist
Testimonials Carousel: What People Say
Mar 13, 2025
Coloring with Parkinson's
Mar 13, 2025
Mar 13, 2025
Nov 28, 2024
Very Encouraging and Refreshing
Nov 28, 2024
Nov 28, 2024
Apr 19, 2024
Stuck on Pause
Apr 19, 2024
Apr 19, 2024
Aug 12, 2023
Photobiomodulation or Red Light Therapy
Aug 12, 2023
Aug 12, 2023
Jul 7, 2022
Tremors Reduced
Jul 7, 2022
Jul 7, 2022
Mar 29, 2022
Accessible Knowledge
Mar 29, 2022
Mar 29, 2022
Oct 19, 2021
Staying Positive
Oct 19, 2021
Oct 19, 2021
Jul 28, 2021
Suggestions for Exploration
Jul 28, 2021
Jul 28, 2021
Jun 20, 2021
Educative Posts
Jun 20, 2021
Jun 20, 2021
Mar 24, 2021
Parallels with Trauma
Mar 24, 2021
Mar 24, 2021
Feb 4, 2021
Correcting Dysfunctional Sleep
Feb 4, 2021
Feb 4, 2021
Oct 27, 2020
REM Sleep Behaviour Disorder
Oct 27, 2020
Oct 27, 2020
Aug 11, 2020
Yoga Therapy
Aug 11, 2020
Aug 11, 2020
Nov 27, 2019
Strategies of Recovery
Nov 27, 2019
Nov 27, 2019
Sep 3, 2019
Applications of Polyvagal Theory
Sep 3, 2019
Sep 3, 2019
May 24, 2019
Hope and Inspiration
May 24, 2019
May 24, 2019
Feb 7, 2019
Headed in the Right Direction
Feb 7, 2019
Feb 7, 2019
Sep 10, 2018
Husband Diagnosed
Sep 10, 2018
Sep 10, 2018
Sep 10, 2018
Making Changes
Sep 10, 2018
Sep 10, 2018
Jun 21, 2018
Craniosacral Therapy
Jun 21, 2018
Jun 21, 2018
May 27, 2018
Music is Medicine
May 27, 2018
May 27, 2018
Apr 26, 2018
Social Isolation
Apr 26, 2018
Apr 26, 2018
Mar 31, 2018
From Malta
Mar 31, 2018
Mar 31, 2018
Mar 6, 2018
Impactful Discoveries
Mar 6, 2018
Mar 6, 2018
Mar 6, 2018
Co-Regulation
Mar 6, 2018
Mar 6, 2018
Feb 6, 2018
Outstanding Information
Feb 6, 2018
Feb 6, 2018
Jan 21, 2018
Slowing Down Progression
Jan 21, 2018
Jan 21, 2018
Oct 25, 2017
Exploring All the Potential Causes
Oct 25, 2017
Oct 25, 2017
Sep 10, 2017
Can-Do Attitude
Sep 10, 2017
Sep 10, 2017
Aug 28, 2017
Connecting the Dots
Aug 28, 2017
Aug 28, 2017

©2017-2024 Gary Sharpe, ©2016 Gary Sharpe and Deb Helfrich

Contact Us

Medical Disclaimer

Website Terms & Conditions